Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Sells $126,020.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 2,000 shares of the firm’s stock in a transaction on Thursday, December 26th. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00. Following the transaction, the chief executive officer now directly owns 42,497 shares in the company, valued at $2,677,735.97. The trade was a 4.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Kewaunee Scientific Stock Performance

Shares of NASDAQ:KEQU traded up $0.23 during trading on Friday, reaching $63.85. The company had a trading volume of 28,625 shares, compared to its average volume of 17,455. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00. The stock’s fifty day moving average price is $41.99 and its 200 day moving average price is $43.12. Kewaunee Scientific Co. has a fifty-two week low of $27.00 and a fifty-two week high of $66.15. The firm has a market capitalization of $183.25 million, a price-to-earnings ratio of 10.12 and a beta of 0.80.

Hedge Funds Weigh In On Kewaunee Scientific

Several institutional investors have recently bought and sold shares of KEQU. Ritholtz Wealth Management purchased a new stake in shares of Kewaunee Scientific in the second quarter valued at about $413,000. Dimensional Fund Advisors LP increased its position in Kewaunee Scientific by 3.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after purchasing an additional 6,132 shares during the period. Renaissance Technologies LLC raised its stake in shares of Kewaunee Scientific by 13.4% during the 2nd quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after buying an additional 10,580 shares in the last quarter. Heron Bay Capital Management acquired a new stake in shares of Kewaunee Scientific in the 2nd quarter valued at approximately $252,000. Finally, De Lisle Partners LLP boosted its stake in shares of Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares in the last quarter. 32.69% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.